T10	Effect 106 122	improves CR rate
T11	Subject 126 186	a small subgroup of patients defined by rhodamine 123 efflux
T12	Treatment 17 24	quinine
T13	Sub-Disorder 166 186	rhodamine 123 efflux
T14	Population 126 142	a small subgroup
T15	Negation_cue 30 33	not
T17	Drug 17 24	quinine
T20	Subject 58 72	adult patients
T21	Age 58 63	adult
T22	Treat-Disorder 78 89	de novo AML
T9	Potential_therapeutic_event 106 114	improves
T19	Potential_therapeutic_event 34 41	improve
E1	Potential_therapeutic_event:T9 arg:T12 arg2:T10 arg3:T11
E2	Potential_therapeutic_event:T19 arg:T12 arg2:T20
R1	has_cue Arg1:E2 Arg2:T15	
R2	has Arg1:T12 Arg2:T22
